Enaleni Pharmaceuticals Limited - Dealing In Secur
ENL
ENL
Enaleni Pharmaceuticals Limited - Dealing In Securities By Directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
DEALING IN SECURITIES BY DIRECTORS
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information relating to the sale on the open market of ordinary shares
by directors of Enaleni and its major subsidiary, Cipla Medpro Holdings (Pty)
Limited ("Cipla Medpro") is disclosed, as follows:
Non-executive Chairman: P C S Luthuli
Company: Enaleni
Date of transaction: 10 May 2006
Number of shares: 750 000
Price: 420,30 cents per share
Value of transaction: R3 152 250
Extent of interest: Direct beneficial
Written clearance to
deal obtained: Yes
Executive director: C Aucamp
Company: Cipla Medpro
Date of transaction: 10 May 2006
Number of shares: 400 000
Price: 420,30 cents per share
Value of transaction: R1 681 200
Extent of interest: Indirect non-beneficial
Written clearance to
deal obtained: Yes
Johannesburg
11 May 2006
Sponsor
Nedbank Capital
Date: 11/05/2006 05:13:26 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
